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Abstract
Objectives: Nonsyndromic cleft lip and palate (NSCLP) is genetically distinct from those with syndromic clefts, 
and accounts for ~70% of cases with Oral clefts. Folate, or vitamin B9, is an essential nutrient in our diet. Allelic 
variants in genes involved in the folate pathway might be expected to have an impact on risk of oral clefts. 
Given the key role of methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) in folate metabolism, it would be of 
significant interest to assess its role in NSCLP etiology.
Study Design: The present study aims at examining the association between MTHFD1 1958G>A polymorphism 
and NSCLP risk by conducting a case-control study in south Indian population. Our sample comprised of 142 cases 
with nonsyndromic clefts and 141 controls without clefts or family history of clefting. The MTHFD1 1958G>A 
polymorphism was genotyped using PCR-RFLP. 
Results: An increased risk was found for the heterozygous 1958GA (OR=2.44; P=0.020) and homozygous 1958AA 
(OR=2.45; P=0.012) genotypes in the children. When the dominant model (AG+AA vs GG) was applied the risk 
remained the same as co-dominant model, but the level of significance increased (OR=2.44; P=0.002). 
Conclusions: The results indicated the MTHFD1 1958G>A polymorphism to be one of the important genetic 
determinants of NSCLP risk in South Indian subjects.
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Introduction
Nonsyndromic cleft lip and palate (NSCLP) is geneti-
cally distinct from those with syndromic clefts, and ac-
counts for ~70% of cases with Oral clefts. The etiology 
of NSCLP is multifactorial, with both genetic and en-
vironmental factors, involving complex gene-gene and 
gene-environment interactions, and it is these interac-
tions that play a critical role (1). Folate, or vitamin B9, 
is an essential nutrient in our diet. Folate metabolism 
provides one-carbon building blocks for the synthesis 
of nucleic acid bases. Folate coenzyme is essential for 
the synthesis of methionine and methionine is required 
for the synthesis of the universal methyl donor S-adeno-
sylmethionine (2). A significant number of hypotheses 
have been published regarding the critical role played 
by the folate during preconception, conception, 
implantation, placentation and embryo or organogene-
sis stages in the manifestation of birth defects. Evidence 
from epidemiologic studies have conclusively shown 
that the prenatal folic acid supplementation reduces risk 
of many congenital anomalies (3).
MTHFD1 is one of the important genes that is involved 
in folate metabolism. MTHFD1 gene encodes trifunc-
tional enzyme 5,10-methylenetetrahydrofolate dehydro-
genase; 5,10-methenyltetrahydrofolate cyclohydrolase 
and 10-formylotetrahydrofolate synthetase (4). This en-
zyme catalyzes the conversion of 1-carbon derivatives 
of tetrahydrofolate (THF) to form the cofactor 10-
formylTHF, which serves as a one-carbon donor for the 
de novo biosynthesis of purines (5). 5,10-methyleneTHF 
that is produced from the condensation of serine and 
THF is utilized in the de novo synthesis of thymidylate 
or otherwise, can be irreversibly reduced by MTHFR to 
5-methylTHF, which is involved in the methylation of 
homocysteine (6,7).
The MTHFD1, gene is located on chromosome 14q23.3 
and spans 71 kb length with a total of 28 exons. Previ-
ous studies have reported the association of MTHFD1 
gene variants with serum folic acid and homocysteine 
levels (8,9). The common G1958A SNP, which is lo-
cated in exon 20 of MTHFD1 gene is associated with 
folate-mediated pathologies such as congenital anoma-
lies (neural tube defects, heart defects, oral clefts) and 
several cancers (10). As the MTHFD1 is a potential can-
didate gene for investigation in relation to cleft pal-
ate risk, and since the previous studies have provided 
contradictory results (11-14), the present case-control 
study was undertaken to examine the association be-
tween MTHFD1 1958G>A and nonsyndromic cleft lip 
and palate in south Indian population.
Material and Methods
- Subjects
The sample consisted of 283 individuals ascertained 
from Cleft and Craniofacial Centre, Sri Ramachandra 
University, Chennai, India. All cases were evaluated by 
two different plastic surgeons for their individual phe-
notypic features, and was also cross verified through 
their medical records. There is no involvement of oral 
pathologist in this study. The case group comprised of 
142 individuals with NSCLP (123 CLP: cleft lip with or 
without cleft palate + 19 CPO: cleft palate only). The 
control group was recruited from the same region, in-
cluded 141 unrelated individuals without clefts or fam-
ily history of clefting in three generations. The subjects 
with congenital malformations or major developmental 
disorders were excluded from the study. The study was 
approved by the Institutional Ethics Committee of the 
Sri Ramachandra University, Chennai, India, and all the 
study subjects gave informed consent. As many of the 
children were minors, the consent was obtained from 
their parents or legal guardian.
- Genotyping
From each study subject 3 ml blood sample was collect-
ed into an EDTA vacutainer. Genomic DNA was iso-
lated from leukocytes using phenol-chloroform extrac-
tion and ethanol precipitation (15). MTHFD1 1958G>A 
(rs2236225) SNP genotyping was performed following 
polymerase chain reaction-restriction fragment length 
polymorphism method (16). Briefly, 310 base pairs (bp) 
fragment of MTHFD1 1958G>A region was amplified 
with the primers of 5’-CCT GGT TTC CAC AGG GCA 
CTC-3’ and 5’-CCA CGT GGG GGC AGA GGC CGG 
AAT ACC GG -3’. The PCR amplicons were incubated 
with the MspI restriction enzyme at 37oC for 4 hours 
and the digested products were resolved by electro-
phoresis on 3% agarose gel. Upon digestion, 310-bp 
PCR product cleaved into two fragments of 282-bp and 
28-bp for the A allele and in the case of G allele the 310-
bp PCR product cleaved into three smaller fragments of 
196-bp, 86-bp and 40-bp. The digested products were 
visualized under UV light by two researchers and inde-
pendently scored the genotypes to minimize errors.
- Statistical Analysis
Allele frequencies were calculated by direct counting 
of alleles. Hardy-Weinberg equilibrium (HWE) analysis 
was performed by comparison of observed and expected 
genotype frequencies using chi-squared goodness-of-fit 
test. The association between different cleft phenotypes 
and MTHFD1 1958G>A polymorphism was analyzed by 
χ2-test. To assess the possible association with NSCLP, 
the comparative analysis for the MTHFD1 1958G>A 
polymorphism distribution was performed for the whole 
group of NSCLP (n=142), as well as for the subgroups of 
patients with CLP (n=123), and CPO (n=19). The same 
control group (n=141) was considered for all the three 
case groups. The risk estimates were calculated with 
the wild type as the reference category. The effect of 
the 1958G>A variant was examined in 3 hypothetical 
risk models, co-dominant, dominant (GA+AA vs.GG) 
Med Oral Patol Oral Cir Bucal. 2014 Nov 1;19 (6):e616-21.                                                                                                                                                  MTHFD1 Gene polymorphisms in NSCLP
e618
and recessive (GA+GG vs.AA) models. The statistical 
analysis was performed using SPSS statistical software 
version 16.0 (SPSS Inc, Chicago, Illinois) for Windows. 
A two-sided p-value <0.05 was considered to be statisti-
cally significant. From the HapMap populations 20kb 
up and downstream SNPs around rs2236225 were ex-
tracted and LD maps were constructed using Haploview 
(17).
Results
The distribution of the MTHFD1 1958G>A variant gen-
otypes and alleles in both cases and NSCLP groups are 
presented in table 1. The proportions of genotypes were 
14.8 % GG, 58.5 % AG, 26.8 % AA in cases and 29.8 
% GG, 48.2 % AC, 22.0 % CC in controls. The A allele 
frequency was 56.0% in cases and 46.1% in controls. 
The genotype distribution in the control group followed 
Hardy Weinberg equilibrium (P=0.726). Significant dif-
ference in allele frequencies were found between con-
trol and the NSCLP groups (Table 2). OR and 95% CI 
were calculated to assess the impact of the MTHFD1 
1958G>A variant on NSCLP risk (Table 2). Signifi-
cantly increased NSCLP risk was found for both het-
erozygous (OR=2.44; 95% CI: 1.32-4.51; p=0.004) and 
homozygous (OR=2.45; 95% CI: 1.20-4.97; p=0.012) 
genotypes. Increased NSCLP risk was also found un-
Control
(%) 
Overall 
clefts (%) 
CLP (%) CPO (%) 
Genotype distribution 
GG 42 (29.8) 21 (14.8) 19 (15.5) 2 (10.5) 
AG 68 (48.2) 83 (58.5) 72 (58.5) 11 (57.9) 
AA 31 (22.0) 38 (26.8) 32 (26.0) 6 (31.6) 
Allele frequency 
G allele 152 (53.9) 125 (44.0) 110 (44.7) 15 (39.5) 
A allele 130 (46.1) 159 (56.0) 136 (55.3) 23 (60.5) 
Test for HWE 
Chi-square 0.123 4.913 4.162 0.851 
P-value 0.726 0.027 0.041 0.356 
Table 1. Genotype distribution and allele frequencies of the MTHFD1 
1958G>A SNP in cleft lip and palate.
MTHFD1 1958G>A OR (95% CI) P-value
Overall clefts
GG Reference
AG 2.44 (1.32-4.51) 0.004 
AA 2.45 (1.20-4.97) 0.012 
AG+AA vs. GG 2.44 (1.36-4.30) 0.002 
GG+AG vs. AA 1.30 (0.75-2.24) 0.350 
G allele Reference  
A allele 1.49 (1.07-2.07) 0.018 
CLP
GG Reference  
AG 2.34 (1.24-4.42) 0.008 
AA 2.28 (1.09-4.75) 0.026 
AG+AA vs. GG 2.32 (1.26-4.26) 0.005 
GG+AG vs. AA 1.25 (0.71-2.20) 0.443 
G allele Reference  
A allele 1.44 (1.02-2.03) 0.035 
CPO
GG Reference
AG 3.39 (0.72-16.08) 0.105 
AA 4.06 (0.77-21.51) 0.079 
AG+AA vs. GG 3.60 (0.79-16.30) 0.077 
GG+AG vs. AA 1.64 (0.58-4.66) 0.353 
G allele Reference  
A allele 1.79 (0.89-3.58) 0.094 
Table 2. Results of association tests with MTHFD1 1958G>A 
SNP in cleft lip and palate.
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der dominant (AG+AA vs GG; OR=2.44; 95% CI: 1.36-
4.30; p=0.002) and allelic models (A vs. G; OR = 1.49; 
95% CI: 1.07-2.07; p= 0.018). The recessive effect of 
the 1958A variant (AA vs GG+AG) in cases was not 
significant (OR=1.30; 95% CI: 0.75-2.24; P=0.350). In 
subgroup analysis, the 1958A variant showed a similar 
trend of association for CLP group (Table 2). The MTH-
FD1 1958G>A variant did not show any significant as-
sociation with CPO risk under three different models 
(Table 2). The MTHFD1 1958G>A variant allele fre-
quencies representing different world populations were 
presented in figure 1. The MTHFD1 1958G>A minor 
allele frequency and expected heterozygosity in Indi-
an populations showed little proximity with the other 
Asian, European and American populations, but it was 
quite different from East Asian and African populations 
(Fig. 1).
Fig. 1. The frequency of MTHFD1 1958G>A SNP in the current study compared to the world populations. Forest plot represents 
minor allele frequency (MAF) with 95% confidence interval (CI). 
The frequency data are the same as in ALFRED (http://alfred.med.yale.edu/alfred/SiteTable1A_working.asp?siteuid=SI315597E). 
2N: sample size; eH: expected heterozygosity.
Discussion
The MTHFD1 1958G>A minor allele frequency (A al-
lele) in our controls was 46.1%, which is analogous to 
the frequency of 47% found in the GIH population of 
HapMap (http://hapmap.ncbi.nlm.nih.gov). The fre-
quency reported in the current study is slightly lesser 
than that (55%) found in a small sample of south In-
dians (18). This discrepancy may be due to the varia-
tions in source of samples included in these studies. The 
MTHFD1 1958G>A polymorphism has significantly 
increased the risk of developing cleft lip and palate in 
cases that inherit one copy or two copies of this poly-
morphism. The magnitude of risk (OR) is almost simi-
lar when both genotypes were analyzed separately (GA 
vs. GG=2.44; AA vs. GG=2.45) and also in a dominant 
genetic model of action (AG+AA vs. GG=2.44).
As MTHFD1 is involved in folate pools and folate-de-
pendent reactions, its gene variants have been studied 
extensively for their association with birth defects in 
humans (9,19,20). The results evidenced the associa-
tion between the MTHFD1 1958G>A polymorphism 
and  NSCLP to be convincingly powered and it is not 
in agreement with the earlier studies in Polish (11,12), 
Norwegian (13) and Italian populations (14). Analysis of 
MTHFD1 1958G>A variant in mothers with CLP chil-
dren as well as control mothers revealed the absence of 
statistical differences in allele and genotype frequen-
cies (12,13). MTHFD1 1958G>A has not contributed 
to NSCLP risk in the Polish population separately or 
by showing epistatic interaction with other variants in 
genes of choline and folate metabolism (11). Analysis of 
MTHFD1 A1958G and G401A polymorphisms in 216 
CLP triads of Italian origin revealed relatively low link-
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age disequilibrium between these markers and the alle-
les or haplotypes are not associated with CLP risk (14). 
In a sample of Irish population MTHFD1 1958G>A var-
iant did not show any association between the A allele 
and CPO case status, but CPO case mothers were sig-
nificantly more likely to be AA compared to controls. 
Further, in both case-control and mother-control analy-
ses the variant allele is associated with increased risk of 
CLP (21). Gene-gene interaction analysis showed that 
the MTHFD1 1958G>A variant in combination with 
MTHFR rs2274976 and SLC19A1 rs1051266 predict-
ed the maternal risk for NSCLP in the Brazilian popu-
lation (22). Both TRIMM and HAPLIN methods that 
were used to detect multi-marker effects on oral clefts 
of Norway and Denmark failed to detect the maternal 
effects of MTHFD1 gene variants (23).
There is no consistent evidence to show that the MTH-
FD1 1958G>A polymorphism affected MTHFD1 func-
tion or homocysteine levels. The 1958G>A SNP of 
MTHFD1 results in the substitution of a glutamine (Gln) 
for arginine (Arg) within the 10-formylTHF synthetase 
domain of the MTHFD1 enzyme (5).  When the or-
thologs of MTHFD1 in some species is considered, 
this residue is conserved and contains arginine (rat and 
mouse) or lysine (prokaryotes, insects, plants), substitu-
tion of this amino acid with a glutamine may interfere 
with the structure and function and thereby causing 
disturbances in the folate status or homocysteine levels 
(9,24). Under normal assay conditions, this polymorphism 
had no effect on synthetase activity but it was shown to 
reduce enzyme stability and inhibition of de novo purine 
biosynthesis (25). On the other hand, this variant may be 
in LD with a different, as yet unstudied, variant that modu-
lates MTHFD1 function. Analysis of 20kb up and down-
stream SNPs around rs2236225 from the HapMap data 
demonstrated that the European (CEU, MEX and TSI) and 
Asian (JPT, CHB, CHD and GIH) populations formed the 
single large LD block. The African populations exhibited 
weak LD and formed two to three small LD blocks. Except 
in east Asian populations, the rs2236225 is found to be in 
strong LD with other intronic SNP rs1256142 (Fig. 2).
In summary, the current study demonstrates a strong 
association between MTHFD1 1958G>A and risk of 
NSCLP in south Indian population. Further the  rela-
tionship between additional mutations in the MTHFD1 
gene and serum folate levels or plasma homocysteine 
levels and their interactions could be examined to pro-
vide an eligible conclusion.
Fig. 2. Linkage disequilibrium profiles in different world populations studied in International HapMap Project. Colour coding represents the D'/
LOD values and the values in cells are r2 multiplied by 100.  
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